Cilostazol attenuates mirabegron-induced hepatic and renal toxicity in rats: regulation of metabolic, oxidative, and inflammatory pathways.
Arch Physiol Biochem
; : 1-13, 2024 Aug 07.
Article
in En
| MEDLINE
| ID: mdl-39109872
ABSTRACT
BACKGROUND:
Mirabegron (MIRG) is a type of ß3 adrenoceptor agonist that is considered an alternative therapy for the treatment of overactive bladder (OAB) symptoms. Cilostazol (CITZ) is a selective inhibitor of phosphodiesterase (III) that has various pharmacological effects. OBJECTVE The current study aimed to highlight the regulatory effects of CITZ on MIRG-induced toxicity. MATERIALS ANDMETHODS:
Male rats were divided into six groups. Blood samples were collected to determine different hepatic and kidney function levels along with serum protein electrophoresis and inflammatory factor levels. Histopathological studies and oxidative stress (OS) were also assessed. Kidney and hepatic damage were detected following the administration of MIRG, especially at high doses, due to elevated OS, inflammation, and apoptotic marker levels.RESULTS:
Rats receiving CITZ exhibited significant improvements in both hepatic and kidney functions, with decreased inflammation and OS.CONCLUSION:
CITZ administration plays a beneficial role in alleviating hepatic and nephrotoxicity induced by MIRG by inhibiting OS and inflammation.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Arch Physiol Biochem
Journal subject:
BIOQUIMICA
/
FISIOLOGIA
Year:
2024
Document type:
Article
Affiliation country:
Egipto